Table 2 Estimated hazard ratios for time to adverse outcome (ICU admission or death) from a model for a one standard deviation change in each body composition measure accounting for competing risks (N = 124).

From: Body composition predictors of outcome in patients with COVID-19

Body composition measure (CSA)

Standard deviation (cm2)

Hazard ratio (95% CI)

p value

VAT

110

1.28 (0.93, 1.76)

0.130

VAT/SAT ratio

0.38

1.30 (1.04, 1.62)

0.022

TAT

213

1.58 (0.95, 2.63)

0.078

Muscle

37

0.80 (0.48, 1.35)

0.410

IMAT

13.7

1.44 (1.10, 1.89)

0.008

  1. Each model was additionally adjusted for age, sex, race (White/Black/Hispanic/other), type 2 diabetes, cardiovascular or metabolic disease not including type 2 diabetes, (binary), and body mass index (natural cubic splines with three nodes). Hazard ratios refer to subdistributional proportional hazard ratios for ICU admission and/or death, obtained from competing risks models.
  2. CSA cross-sectional area, VAT visceral adipose tissue, SAT subcutaneous adipose tissue, IMAT intermuscular adipose tissue.